Insider · CIK 0001491847

Oki Mark K

Reports to the SEC for 4 companies · BOTHELL, WA

sec.gov

Transactions

Companies

Filings

CIK

0001491847

Forms 4 and 5

Insider transactions

45 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-28	ACHVACHIEVE LIFE SCIENCES, INC. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+180K sh	—	—	180,000
2025-09-18	ACHVACHIEVE LIFE SCIENCES, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+168K sh	—	—	178,000
2025-09-18	ACHVACHIEVE LIFE SCIENCES, INC.S Sale	Chief Financial Officer	SSale	−50.1K sh	$2.92	−$146K	127,940
2025-09-18	ACHVACHIEVE LIFE SCIENCES, INC. · Performance Restricted Stock Unit (PRSU)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−168K sh	—	—	0
2025-09-04	ACHVACHIEVE LIFE SCIENCES, INC. · Performance Restricted Stock UnitA Award	Chief Financial Officer	AAward	−168K sh	—	—	0
2025-03-17	ACHVACHIEVE LIFE SCIENCES, INC.P Purchase	Chief Financial Officer	PPurchase	+10K sh	$2.89	+$28.9K	10,000
2024-12-06	ACHVACHIEVE LIFE SCIENCES, INC. · Common Stock Options (right to buy)A Award	Chief Financial Officer	AAward	+72K sh	—	—	72,000
2024-12-06	ACHVACHIEVE LIFE SCIENCES, INC. · Performance Restricted Stock Unit (PRSU)A Award	Chief Financial Officer	AAward	+168K sh	—	—	168,000
2023-08-11	AYTUAYTU BIOPHARMA, INC · Employee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+13K sh	—	—	13,000
2022-11-18	AYTUAYTU BIOPHARMA, INCP Purchase	Chief Financial Officer	PPurchase	+90K sh	$0.23	+$20.7K	190,000
2022-11-18	AYTUAYTU BIOPHARMA, INCA Award	Chief Financial Officer	AAward	+90K sh	$0.23	+$20.7K	190,000
2022-01-17	AYTUAYTU BIOPHARMA, INCA Award	Chief Financial Officer	AAward	+100K sh	—	—	100,000
2020-01-29	VIVUS INCEmployee Stock Option (right to buy)A Award	Chief Financial Officer & CAO	AAward	+32K sh	—	—	32,000
2019-11-14	VIVUS INCA Award	Chief Financial Officer & CAO	AAward	+700 sh	$2.38	+$1,666	12,100
2019-05-14	VIVUS INCA Award	Chief Financial Officer & CAO	AAward	+700 sh	$2.84	+$1,988	11,400
2019-01-23	VIVUS INCEmployee Stock Option (right to buy)A Award	Chief Financial Officer & CAO	AAward	+32K sh	—	—	32,000
2018-11-14	VIVUS INCA Award	Chief Financial Officer & CAO	AAward	+700 sh	$2.71	+$1,897	10,700
2018-11-06	VIVUS INCP Purchase	Chief Financial Officer & CAO	PPurchase	+10K sh	$4.07	+$40.7K	10,000
2018-04-30	VIVUS INCEmployee Stock Option (right to buy)A Award	Chief Financial Officer & CAO	AAward	+200K sh	—	—	200,000
2018-02-02	VIVUS INCEmployee Stock Option (right to buy)A Award	Chief Financial Officer & CAO	AAward	+350K sh	—	—	350,000
2017-01-27	VIVUS INCEmployee Stock Option (right to buy)A Award	Chief Financial Officer & CAO	AAward	+385K sh	—	—	385,000
2016-01-22	VIVUS INCEmployee Stock Option (right to buy)A Award	Chief Financial Officer & CAO	AAward	+93.5K sh	—	—	93,500
2015-10-30	VIVUS INCEmployee Stock Option (right to buy)A Award	Chief Financial Officer & CAO	AAward	+225K sh	—	—	225,000
2015-07-22	Alexza Pharmaceuticals Inc.Stock Option (right to buy)A Award	Former SVP, CFO, Secretary	AAward	+125K sh	—	—	125,000
2013-03-29	Alexza Pharmaceuticals Inc.A Award	Former SVP, CFO, Secretary	AAward	+43.8K sh	$4.42	+$193K	49,538
2013-03-29	Alexza Pharmaceuticals Inc.Stock Option (right to buy)A Award	Former SVP, CFO, Secretary	AAward	+87.5K sh	—	—	87,500
2012-08-27	Alexza Pharmaceuticals Inc.S Sale	Former SVP, CFO, Secretary	SSale	−10K sh	$4.14	−$41.4K	3,788
2012-07-26	Alexza Pharmaceuticals Inc.Stock Option (right to buy)A Award	Former SVP, CFO, Secretary	AAward	+10K sh	—	—	10,000
2012-07-26	Alexza Pharmaceuticals Inc.Stock Option (right to buy)A Award	Former SVP, CFO, Secretary	AAward	+25K sh	—	—	25,000
2012-06-06	Alexza Pharmaceuticals Inc.S Sale	Former SVP, CFO, Secretary	SSale	−31.9K sh	$0.34	−$10.8K	137,896
2012-05-10	Alexza Pharmaceuticals Inc.A Award	Former SVP, CFO, Secretary	AAward	+100K sh	—	—	169,769
2012-03-23	Alexza Pharmaceuticals Inc.A Award	Former SVP, CFO, Secretary	AAward	+31.9K sh	—	—	69,769
2011-07-28	Alexza Pharmaceuticals Inc.Stock Option (right to buy)A Award	Former SVP, CFO, Secretary	AAward	+110K sh	—	—	110,000
2011-02-22	Alexza Pharmaceuticals Inc.Stock Option (right to buy)D Disposition to Issuer	Former SVP, CFO, Secretary	DDisposition to Issuer	−20K sh	—	—	0
2011-02-22	Alexza Pharmaceuticals Inc.Stock Option (right to buy)A Award	Former SVP, CFO, Secretary	AAward	+5,000 sh	—	—	5,000
2011-02-22	Alexza Pharmaceuticals Inc.Stock Option (right to buy)D Disposition to Issuer	Former SVP, CFO, Secretary	DDisposition to Issuer	−636 sh	—	—	0
2011-02-22	Alexza Pharmaceuticals Inc.Stock Option (right to buy)A Award	Former SVP, CFO, Secretary	AAward	+159 sh	—	—	159
2011-02-22	Alexza Pharmaceuticals Inc.Stock Option (right to buy)D Disposition to Issuer	Former SVP, CFO, Secretary	DDisposition to Issuer	−1,434 sh	—	—	0
2011-02-22	Alexza Pharmaceuticals Inc.Stock Option (right to buy)A Award	Former SVP, CFO, Secretary	AAward	+359 sh	—	—	359
2011-02-22	Alexza Pharmaceuticals Inc.Stock Option (right to buy)D Disposition to Issuer	Former SVP, CFO, Secretary	DDisposition to Issuer	−7,500 sh	—	—	0
2011-02-22	Alexza Pharmaceuticals Inc.Stock Option (right to buy)A Award	Former SVP, CFO, Secretary	AAward	+3,750 sh	—	—	3,750
2011-02-22	Alexza Pharmaceuticals Inc.Stock Option (right to buy)D Disposition to Issuer	Former SVP, CFO, Secretary	DDisposition to Issuer	−7,323 sh	—	—	0
2011-02-22	Alexza Pharmaceuticals Inc.Stock Option (right to buy)A Award	Former SVP, CFO, Secretary	AAward	+4,882 sh	—	—	4,882
2011-02-22	Alexza Pharmaceuticals Inc.Stock Option (right to buy)D Disposition to Issuer	Former SVP, CFO, Secretary	DDisposition to Issuer	−40K sh	—	—	0
2011-02-22	Alexza Pharmaceuticals Inc.Stock Option (right to buy)A Award	Former SVP, CFO, Secretary	AAward	+26.7K sh	—	—	26,667

Recent filings

Accepted (ET)
Jan 304
Oki Mark K0001193125-26-031801
SEC(opens sec.gov)
Sep 224
Oki Mark K0001193125-25-211404
SEC(opens sec.gov)
Sep 84
Oki Mark K0000950170-25-113606
SEC(opens sec.gov)
Mar 194
Oki Mark K0000950170-25-042074
SEC(opens sec.gov)
Dec 94
Oki Mark K0000950170-24-134600
SEC(opens sec.gov)
Aug 154
Oki Mark K0000912282-23-000296
SEC(opens sec.gov)
Nov 284/A
Oki Mark K0001567619-22-020920
SEC(opens sec.gov)
Nov 214
Oki Mark K0001654954-22-015598
SEC(opens sec.gov)
Jan 194
Oki Mark K0001567619-22-001304
SEC(opens sec.gov)
Jan 314
Oki Mark K0001123292-20-000198
SEC(opens sec.gov)
Nov 184
Oki Mark K0001123292-19-001282
SEC(opens sec.gov)
May 154
Oki Mark K0001123292-19-000774
SEC(opens sec.gov)
Jan 254
Oki Mark K0001123292-19-000203
SEC(opens sec.gov)
Nov 164
Oki Mark K0001123292-18-001066
SEC(opens sec.gov)
Nov 74
Oki Mark K0001123292-18-001056
SEC(opens sec.gov)
May 24
Oki Mark K0001123292-18-000678
SEC(opens sec.gov)
Feb 64
Oki Mark K0001123292-18-000266
SEC(opens sec.gov)

Companies

Address

22722 29TH DR SE SUITE 100

BOTHELL, WA, 98021